Integrated Drug Discovery
In the realm of integrated drug discovery, the swift and effective incorporation of essential assay data into the iterative design and synthesis of potential drug molecules plays a pivotal role in ensuring the timely delivery of promising drug candidates. This process is a crucial aspect of the drug development process, enabling the identification and optimisation of lead compounds.
Whilst many large organisations strive to break down silo mentalities that segment disciplines and create barriers to team-based problem solving, Sygnature has, from day one, adopted a highly collaborative and adaptable team structure, which is essential for streamlining the drug development process. As an integrated CRO, our teams are co-located in mixed discipline labs to facilitate effective communication and problem solving, allowing us to respond quickly to the changing needs of your research project.
Integrated Drug Development Process
Communication with customers and their authorised consultants is facilitated by our excellent informatics platform to enable transparent discussion and review or revision of project strategies, an integral part of the drug development process. Discover more about what it means to work with Sygnature here.
Sygnature has successfully recruited many industry-experienced scientists from across the globe to enrich and augment the drug hunting knowledge base of our founding scientists, contributing significantly to the expertise required for the drug development process. Our scientific teams are invariably highly qualified, and each program is allocated a project leader with relevant drug discovery experience, a key figure in guiding the drug development process. All are keen to collaborate with customers to achieve their shared goals in the drug development process. Our teams’ intellectual contribution is highly valued by our customers and recognized by co-authorship in numerous published patents assigned to and held by our customer companies, showcasing their vital role in the drug development process.